CDH17 and neoplasm: Differential and enrichment analyses revealed significantly higher expression of genes related to cell adhesion, ribosome, cadherin, enzyme inhibitor, ubiquitin, etc., in the tumor cells remaining in patients after neoadjuvant therapy and cisplatin-insensitive cell lines.